Mode
Text Size
Log in / Sign up
N/A Completed N=41 Randomized Treatment

Exercise Dosing for Pain in Healthy Participants

Source: ClinicalTrials.gov NCT03642938 ↗
Enrolled (actual)
41
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcomePrimary: Intervention Effects on Mechanical Sensitivity Threshold — 125.6; 93.56; 63.04; 70.27 100*Value at 24 hours/Value at Baseline

Summary

In this study investigators will examine the effect of dose related to exercise therapy for pain in healthy adult humans. An acute pain model will be employed to study the effect of exercise dose on pain. Acute pain models are currently used to study pain (both acute and chronic) in human samples as there is currently no chronic pain model.

Outcome Measures

OutcomeResultp-value
PRIMARY
Intervention Effects on Mechanical Sensitivity Threshold
125.6; 93.56; 63.04; 70.27; 299; 396.7
PRIMARY
Intervention Effects on Constant Heat Pain Intensity
88.79; 80.03; 80.16; 110.4; 59.46; 114.3
PRIMARY
Intervention Effects on Constant Heat Pain Unpleasantness
110.1; 130.7; 110.6; 79.63; 65.94; 137.5
PRIMARY
Intervention Effects on Radiant Heat Sensitivity
99.08; 101.2; 99.8; 100.8; 100.1; 101.5
PRIMARY
Intervention Effects on Radiant Heat Pain
98.65; 96.83; 97.10; 99.2; 100.6; 99.59
PRIMARY
Intervention Effects on Pressure Pain Threshold
135.5; 143.3; 150.1; 111; 122.6; 134.7
PRIMARY
Intervention Effects on Constant Pressure Pain Intensity
93.3; 49.6; 67.26; 157.6; 89.6; 85.37
PRIMARY
Intervention Effects on Constant Pressure Pain Unpleasantness
92.61; 46.62; 46.58; 127.9; 80.51; 76.56
SECONDARY
Heart Rate
124.12; 115.87; 112.349; 121.443; 118.8; 110.16
SECONDARY
Borg Rate of Perceived Exertion (RPE)
144; 159.4; 152.45; 147.2; 156.3; 161.3

Eligibility Criteria

Inclusion Criteria

  • Between age 18-40
  • Normal BMI (18.5-25.0)
  • Heart Rate (HR) 60-100 bmp
  • BP less than or equal to 140/90

Exclusion Criteria

  • Age 40 years
  • Cardiac, respiratory, neurological or musculoskeletal disease
  • Acute pain
  • Chronic pain condition
  • Diabetes
  • BMI ≥ 25.1 or ≤ 18.4
  • Regular participation in high intensity athletic/sporting activities
  • Sedentary
  • Anxiety or depression disorders
  • Tape allergy
  • Currently pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03642938). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search